InterCept Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire InterCept Pharmaceuticals, Inc.
Quantité totale PI 202
Rang # Quantité totale PI 6 567
Note d'activité PI 2,7/5.0    59
Rang # Activité PI 12 046
Symbole boursier ICPT (nasdaq)
ISIN US45845P1084
Capitalisation 1,100M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

58 17
11 24
48 11
33
 
Dernier brevet 2025 - Crystalline forms of a farnesoid...
Premier brevet 2002 - Steroids as agonists for fxr
Dernière marque 2022 - SEKTAYOS
Première marque 2014 - INTERCEPT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Crystalline forms of a farnesoid x receptor agonist. Provided are crystalline forms of a farnesoi...
2024 Invention Farnesoid x receptor modulators. The present invention provides a compound of formula (I): or a ...
Invention Preparation and uses of obeticholic acid. The present invention relates to obeticholic acid: T...
Invention Methods and intermediates for the preparation of bile acid derivatives. The present disclosure re...
2023 Invention Uses of farnesoid x receptor agonists. The present invention relates to FXR agonist compounds and...
Invention Methods for ameliorating cognitive impairment using bile acid derivatives. The disclosure relates...
Invention Uses of farnesoid x receptor agonists. The present invention relates to FXR agonist compounds an...
Invention Farnesoid x receptor modulators. The present invention provides a compound of formula (I): The...
Invention Combination therapy. The present disclosure relates to a combination of an FXR agonist and a fib...
Invention Combination therapy. The present disclosure relates to a combination of an FXR agonist and a fibr...
2022 Invention Isotopically labeled bile acid derivatives. The present application relates to isotopically labe...
P/S Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions
Invention Tgr5 modulators and methods of use thereof. The application relates to compounds of formula A: ...
Invention Pharmaceutical compositions for combination therapy. The present invention relates to a pharmaceu...
Invention Pharmaceutical compositions for combination therapy. The present invention relates to a pharmace...
2021 Invention Compositions of obeticholic acid and methods of use. The disclosure relates to obeticholic acid ...
Invention Methods of treating coronaviral infection with obeticholic acid. This present application provide...
Invention Methods of using obeticholic acid. The disclosure relates to methods of using obeticholic acid o...
Invention Methods and intermediates for the preparation of bile acid derivatives. The present disclosure r...
Invention Farnesoid x receptor modulators. The present application provides a compound of formula I: are ...
Invention Treatment of fibrosis using fxr ligands. The present invention relates to a method for inhibitin...
2020 P/S Providing a website featuring information about health and wellness, namely, information in the f...
Invention Tgr5 modulators and methods of use thereof. The invention relates to compounds of Formula A: T...
P/S Pharmaceutical preparations; pharmaceutical preparations for the treatment of liver diseases, dis...
Invention 3-desoxy derivative and pharmaceutical compositions thereof. The present application provides Com...
Invention Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of ch...
Invention Methods of diagnosis and treatment of liver diseases using obeticholic acid. The disclosure rela...
Invention Methods of diagnosis and treatment of liver diseases using obeticholic acid. The disclosure relat...
Invention Compositions of obeticholic acid and methods of use. The disclosure relates to obeticholic acid f...
Invention Treatment and prevention of intestinal inflammatory diseases with a bile acid derivative. The pr...
Invention Treatment and prevention of intestinal inflammatory diseases with a bile acid derivative. e.g.e.g...
P/S Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharma...
2019 Invention Farnesoid x receptor modulators. The present invention provides a compound of formula (I): 6 are...
Invention Methods of using obeticholic acid. The disclosure relates to methods of using obeticholic acid or...
P/S Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations...
Invention Methods of treating cancer. The present invention relates to methods of treating or preventing c...
P/S Downloadable information, slide decks, video content, brochures, publications in the field of liv...
P/S Downloadable information, namely, slide decks, consisting of text, images, photographs, tables, g...
P/S Providing a website featuring information in the field of liver diseases and treatments
2018 Invention Treatment of fibrosis using fxr ligands. The present invention relates to a method for inhibiting...
Invention Isotopically labeled bile acid derivatives. The present application relates to isotopically label...
Invention Crystalline forms of obeticholic acid. The crystalline forms of obeticholic acid and methods of ...
Invention Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof. The appli...
2017 Invention Crystalline forms of a bile acid derivative. A crystalline form of a bile acid compound and meth...
P/S Medical and scientific research, including conducting clinical trials and studies for pharmaceuti...
P/S Software application tool for use in the field of liver and intestinal diseases for sending, view...
P/S Software application tool for use in the field of liver and intestinal diseases.
Invention Film-coated tablet having high chemical stability of active ingredient. The present invention rel...
2016 P/S Providing funding and financial assistance for research, studies and programs related to disease ...
Invention Methods and intermediates for the preparation bile acid derivatives. The present invention relate...
P/S Providing information, news and commentary in the field of chronic liver diseases or gastrointest...
P/S Computer application software for mobile phones, portable media players, handheld computers, tabl...
P/S computer application software for mobile phones, portable media players, handheld computers, tabl...
P/S Computer application software for mobile phones, portable media players, handheld computers, tab...
P/S Administration of programs to provide medicines at low or no cost to underserved populations; Adm...
P/S Administration of programs to provide medicines at low or no cost to underserved populations; ad...
P/S Administration of programs to provide medicines at no cost to patients in urgent need and providi...
P/S Providing funding and financial assistance for research, studies and programs related to disease...
2003 Invention Steroids as agonists for fxr. The invention relates to compounds of formula (I): wherein R is e...